SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO)

141 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q2 2024.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 63.2M shares of 84.7M outstanding shares and own 74.55% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (7.71M shares), BlackRock Inc. (6.91M shares), Point72 Asset Management, L.P. (4.45M shares), MILLENNIUM MANAGEMENT LLC (4.36M shares), VANGUARD GROUP INC (3.56M shares), MPM BIOIMPACT LLC (3.04M shares), Samsara BioCapital, LLC (2.2M shares), Kynam Capital Management, LP (2.02M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2M shares), and BAILLIE GIFFORD & CO (1.85M shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.